MARKET

CSBR

CSBR

Champions
NASDAQ

Real-time Quotes | Nasdaq Last Sale

8.96
+0.12
+1.36%
Closed 16:00 08/07 EDT
OPEN
8.79
PREV CLOSE
8.84
HIGH
9.19
LOW
8.79
VOLUME
14.39K
TURNOVER
--
52 WEEK HIGH
10.89
52 WEEK LOW
4.020
MARKET CAP
114.03M
P/E (TTM)
-53.7815
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average CSBR stock price target is 11.00 with a high estimate of 12.00 and a low estimate of 10.00.

EPS

CSBR News

More
Champions Oncology slumps on Q4 reports
Seeking Alpha · 07/28 19:38
Champions Oncology, Inc. (CSBR) CEO Ronnie Morris on Q4 2020 Results - Earnings Call Transcript
Seeking Alpha · 07/27 23:24
Champions Oncology EPS misses by $0.18, beats on revenue
Seeking Alpha · 07/27 20:14
Champions Oncology Q4 Sales $8.80M Beat $8.29M Estimate
Champions Oncology (NASDAQ:CSBR) reported quarterly sales of $8.80 million which beat the analyst consensus estimate of $8.29 million by 6.15 percent. This is a 14.02 percent increase over sales of $7.72 million the
Benzinga · 07/27 20:09
The Daily Biotech Pulse: Mixed Tidings From Novavax, Radius Health Out-licenses Breast Cancer Drug, 3 IPOs
  Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 23)
Benzinga · 07/24 11:15
The Truth About Market Timing - June 17, 2020
Zacks · 06/17 14:37
If You Had Bought Champions Oncology (NASDAQ:CSBR) Shares Three Years Ago You'd Have Made 278%
Simply Wall St. · 05/27 12:05
Timing the Market, Is it Possible? - April 28, 2020
Zacks · 04/28 14:50

Industry

Biotechnology & Medical Research
-0.18%
Pharmaceuticals & Medical Research
+0.08%

Hot Stocks

Symbol
Price
%Change

About CSBR

Champions Oncology, Inc. is engaged in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The Company’s TumorGraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The Company uses this technology, in conjunction with related services, to offer solutions for two consumer groups: Translational Oncology Solutions (TOS) and Personalized Oncology Solutions (POS). The Company’s TOS business offers a technology platform to pharmaceutical and biotechnology companies using TumorGraft studies. POS assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The Company subsidiaries include Champions Oncology (Israel) and Limited and Champions Biotechnology U.K., Limited.
More

Webull offers kinds of Champions Oncology Inc stock information, including NASDAQ:CSBR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CSBR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CSBR stock methods without spending real money on the virtual paper trading platform.